tiprankstipranks
Trending News
More News >
IGC Pharma (IGC)
:IGC
US Market

IGC Pharma (IGC) Income Statement

Compare
987 Followers

IGC Pharma Income Statement

Last quarter (Q2 2026), IGC Pharma's total revenue was $191.00K, a decrease of -25.68% from the same quarter last year. In Q2, IGC Pharma's net income was $-1.82M. See IGC Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 1.27M$ 1.34M$ 911.00K$ 397.00K$ 898.00K
Gross Profit
$ 619.00K$ 733.00K$ -158.00K$ 194.00K$ -349.00K
Operating Expenses
$ 8.06M$ 10.53M$ 11.41M$ 15.62M$ 8.38M
Depreciation and Amortization
$ 618.00K$ 637.00K$ 657.00K$ 651.00K$ 478.00K
EBITDA
$ -6.83M$ -9.16M$ -10.85M$ -14.37M$ -8.33M
Operating Income
$ -7.45M$ -9.80M$ -11.57M$ -15.43M$ -8.72M
Other Income/Expenses
$ 325.00K$ -3.20M$ 65.00K$ 412.00K$ -87.00K
Pretax Income
$ -7.12M$ -13.00M$ -11.51M$ -15.02M$ -8.81M
Net Income
$ -7.12M$ -13.00M$ -11.51M$ -15.02M$ -8.81M
Per Share Metrics
Basic EPS
$ -0.09$ -0.22$ -0.22$ -0.30$ -0.21
Diluted EPS
$ -0.09$ -0.22$ -0.22$ -0.30$ -0.21
Weighted Average Shares Outstanding
76.52M 58.84M 52.58M 49.99M 41.96M
Weighted Average Shares Outstanding (Diluted)
76.52M 58.84M 52.58M 49.99M 41.96M
Currency in USD

IGC Pharma Earnings and Revenue History